Differentiation of stem cells to pancreatic endocrine cells
Details for Australian Patent Application No. 2002241986 (hide)
International Classifications
Event Publications
6 February 2003 Application Open to Public Inspection
Published as AU-A-2002241986
19 February 2004 Amendment Made
The nature of the amendment is: Amend the name of the applicant/patentee to The Government of the United States of America, rep by Sec, Department of Health and Human Services.
20 May 2004 Corrigenda
Amendments, Section 104 - Amendments Made Under the name The Government of the United States of America, rep by Sec, Department of Health and Human Services, Application No. 2002241986 correct the name to read The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this
21 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002241985-Synthesis of beta-lapachone and its intermediates
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser